RESOLV / BNB

LTO / BTC

GUN / FDUSD

GALA / BTC

LTO / USDT

GUN / TRY

GUN / USDT

GUN / USDC

RESOLV / FDUSD

GUN / BNB

BEL / BTC

BEL / TRY

BEL / USDT

SAHARA / BNB

CTK / BNB

CTK / BTC

NEWT / FDUSD

NEWT / TRY

MOVE / BTC

NEWT / BNB

ELLENBARRIE INDUS GASES L

GLOBE CIVIL PROJECTS LTD

CAPITAL TRUST LTD

GABRIEL INDIA LTD

TAMILNADU TELECOMMUNICATI

DANGEE DUMS LIMITED

JEENA SIKHO LIFECARE LTD

ZOTA HEALTH CARE LIMITED

FILATEX FASHIONS LIMITED

CENTURY EXTRUSIONS LTD

PREMIUM PLAST LIMITED

GACM TECHNOLOGIES LIMITED

BOMBAY METRICS S C LTD

ITALIAN EDIBLES LIMITED

HB STOCKHOLDINGS LIMITED

FORCE MOTORS LIMITED

JAYASWAL NECO INDUSTR LTD

SERVICE CARE LIMITED

COROMANDEL INTERNTL. LTD

GVP INFOTECH LIMITED

Click here to get full coverage on ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes - Pharmacy Times

ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes  Pharmacy Times

ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes - Pharmacy Times

Click here to get full coverage on Early SYRUS Data Highlight Safety, Efficacy of AZD0486 in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD - AJMC

Early SYRUS Data Highlight Safety, Efficacy of AZD0486 in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD  AJMC

Early SYRUS Data Highlight Safety, Efficacy of AZD0486 in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD - AJMC

Click here to get full coverage on FDA Fast-Tracks MALT1 Inhibitor in Relapsed/Refractory Waldenström Macroglobulinemia - Targeted Oncology

FDA Fast-Tracks MALT1 Inhibitor in Relapsed/Refractory Waldenström Macroglobulinemia  Targeted Oncology

FDA Fast-Tracks MALT1 Inhibitor in Relapsed/Refractory Waldenström Macroglobulinemia - Targeted Oncology

Click here to get full coverage on Dr Scarfò on the Rationale for Evaluating BGB-16673 in Relapsed/Refractory CLL - OncLive

Dr Scarfò on the Rationale for Evaluating BGB-16673 in Relapsed/Refractory CLL  OncLive

Dr Scarfò on the Rationale for Evaluating BGB-16673 in Relapsed/Refractory CLL - OncLive

Click here to get full coverage on FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma - Hematology Advisor

FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma  Hematology Advisor

FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma - Hematology Advisor

Click here to get full coverage on Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial - Nature

Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial  Nature

Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial - Nature

Click here to get full coverage on Case-Based Insights on Managing Steroid-Refractory cGVHD After Haploidentical Transplant - Pharmacy Times

Case-Based Insights on Managing Steroid-Refractory cGVHD After Haploidentical Transplant  Pharmacy Times

Case-Based Insights on Managing Steroid-Refractory cGVHD After Haploidentical Transplant - Pharmacy Times

Click here to get full coverage on Defining Refractory Migraine for Diagnosis: Insights from an International Delphi Consensus - Neurology live

Defining Refractory Migraine for Diagnosis: Insights from an International Delphi Consensus  Neurology live

Defining Refractory Migraine for Diagnosis: Insights from an International Delphi Consensus - Neurology live

Click here to get full coverage on Unexplained or Refractory Chronic Cough in Adults - The New England Journal of Medicine

Unexplained or Refractory Chronic Cough in Adults  The New England Journal of Medicine

Unexplained or Refractory Chronic Cough in Adults - The New England Journal of Medicine

Click here to get full coverage on Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients - ScienceDirect.com

Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients  ScienceDirect.com

Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients - ScienceDirect.com

Click here to get full coverage on SYRUS Study Explores AZD0486 Safety, Dosing in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD - AJMC

SYRUS Study Explores AZD0486 Safety, Dosing in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD  AJMC

SYRUS Study Explores AZD0486 Safety, Dosing in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD - AJMC

Click here to get full coverage on STAR Locally Prolongs Effective Refractory Period and Increases Ventricular Tachycardia Cycle Length Without Short-Term Scar Formation or Functional Decline: Insights From a Translational Porcine Model Study - American Heart Association Journals

STAR Locally Prolongs Effective Refractory Period and Increases Ventricular Tachycardia Cycle Length Without Short-Term Scar Formation or Functional Decline: Insights From a Translational Porcine Model Study  American Heart Association Journals

STAR Locally Prolongs Effective Refractory Period and Increases Ventricular Tachycardia Cycle Length Without Short-Term Scar Formation or Functional Decline: Insights From a Translational Porcine Model Study - American Heart Association Journals

Click here to get full coverage on Durable Responses Are Achievable for Steroid-Refractory Chronic GVHD - Targeted Oncology

Durable Responses Are Achievable for Steroid-Refractory Chronic GVHD  Targeted Oncology

Durable Responses Are Achievable for Steroid-Refractory Chronic GVHD - Targeted Oncology

Click here to get full coverage on Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3 - Nature

Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3  Nature

Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3 - Nature

Click here to get full coverage on Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia - The New England Journal of Medicine

Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia  The New England Journal of Medicine

Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia - The New England Journal of Medicine

Click here to get full coverage on Binder jetting of spinel-based refractory materials – processing, microstructure and properties - ScienceDirect.com

Binder jetting of spinel-based refractory materials – processing, microstructure and properties  ScienceDirect.com

Binder jetting of spinel-based refractory materials – processing, microstructure and properties - ScienceDirect.com

Click here to get full coverage on Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial - Nature

Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial  Nature

Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial - Nature

Click here to get full coverage on Efficacy of vacuum erectile device in refractory erectile dysfunction: a systematic review and meta-analysis - Nature

Efficacy of vacuum erectile device in refractory erectile dysfunction: a systematic review and meta-analysis  Nature

Efficacy of vacuum erectile device in refractory erectile dysfunction: a systematic review and meta-analysis - Nature

Click here to get full coverage on Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey - Nature

Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey  Nature

Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey - Nature

Click here to get full coverage on Oncolytic virus VG161 in refractory hepatocellular carcinoma - Nature

Oncolytic virus VG161 in refractory hepatocellular carcinoma  Nature

Oncolytic virus VG161 in refractory hepatocellular carcinoma - Nature

Click here to get full coverage on Refractory Angina - www.heart.org

Refractory Angina - www.heart.org

Click here to get full coverage on Current Treatment Approaches for Relapsed/Refractory Diffuse Large B-Cell Lymphoma - Pharmacy Times

Current Treatment Approaches for Relapsed/Refractory Diffuse Large B-Cell Lymphoma  Pharmacy Times

Current Treatment Approaches for Relapsed/Refractory Diffuse Large B-Cell Lymphoma - Pharmacy Times

Click here to get full coverage on CARTITUDE-1 Trial Shows Unprecedented 5-Year Remission in Relapsed/Refractory Multiple Myeloma: Sundar Jagannath, MBBS - AJMC

CARTITUDE-1 Trial Shows Unprecedented 5-Year Remission in Relapsed/Refractory Multiple Myeloma: Sundar Jagannath, MBBS  AJMC

CARTITUDE-1 Trial Shows Unprecedented 5-Year Remission in Relapsed/Refractory Multiple Myeloma: Sundar Jagannath, MBBS - AJMC

Click here to get full coverage on In-situ alloying of nonequiatomic TiNbMoTaW refractory bio-high entropy alloy via laser powder bed fusion: Achieving suppressed microsegregation and texture formation - ScienceDirect.com

In-situ alloying of nonequiatomic TiNbMoTaW refractory bio-high entropy alloy via laser powder bed fusion: Achieving suppressed microsegregation and texture formation  ScienceDirect.com

In-situ alloying of nonequiatomic TiNbMoTaW refractory bio-high entropy alloy via laser powder bed fusion: Achieving suppressed microsegregation and texture formation - ScienceDirect.com

Click here to get full coverage on Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes | Blood Cancer Journal - Nature

Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes | Blood Cancer Journal  Nature

Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes | Blood Cancer Journal - Nature

Click here to get full coverage on Cilta-Cel Emerges as a SOC in Lenalidomide-Refractory Multiple Myeloma - OncLive

Cilta-Cel Emerges as a SOC in Lenalidomide-Refractory Multiple Myeloma  OncLive

Cilta-Cel Emerges as a SOC in Lenalidomide-Refractory Multiple Myeloma - OncLive

Click here to get full coverage on Evaluating refractory material performance in pyrometallurgical recycling of lithium-ion batteries under a reducing atmosphere - ScienceDirect.com

Evaluating refractory material performance in pyrometallurgical recycling of lithium-ion batteries under a reducing atmosphere  ScienceDirect.com

Evaluating refractory material performance in pyrometallurgical recycling of lithium-ion batteries under a reducing atmosphere - ScienceDirect.com

Click here to get full coverage on FDA Fast Track: Schrödinger's SGR-1505 Targets Resistant Blood Cancer with Promising Phase 1 Data - Stock Titan

FDA Fast Track: Schrödinger's SGR-1505 Targets Resistant Blood Cancer with Promising Phase 1 Data  Stock Titan

FDA Fast Track: Schrödinger's SGR-1505 Targets Resistant Blood Cancer with Promising Phase 1 Data - Stock Titan

Click here to get full coverage on Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma - The New England Journal of Medicine

Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma  The New England Journal of Medicine

Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma - The New England Journal of Medicine

Click here to get full coverage on Two-shot optimization of compositionally complex refractory alloys - ScienceDirect.com

Two-shot optimization of compositionally complex refractory alloys  ScienceDirect.com

Two-shot optimization of compositionally complex refractory alloys - ScienceDirect.com

Click here to get full coverage on High-throughput design of a light and strong refractory eutectic medium entropy alloy with outstanding He-ion irradiation resistance - Science | AAAS

High-throughput design of a light and strong refractory eutectic medium entropy alloy with outstanding He-ion irradiation resistance  Science | AAAS

High-throughput design of a light and strong refractory eutectic medium entropy alloy with outstanding He-ion irradiation resistance - Science | AAAS

Click here to get full coverage on Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study - The Lancet

Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study  The Lancet

Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study - The Lancet

Click here to get full coverage on Rotational deformation twins in a HfNbTaTiZr refractory high entropy alloy - ScienceDirect.com

Rotational deformation twins in a HfNbTaTiZr refractory high entropy alloy  ScienceDirect.com

Rotational deformation twins in a HfNbTaTiZr refractory high entropy alloy - ScienceDirect.com

Click here to get full coverage on Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms (FUTURE) in the UK: a multicentre, superiority, parallel, open-label, randomised controlled trial - The Lancet

Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms (FUTURE) in the UK: a multicentre, superiority, parallel, open-label, randomised controlled trial  The Lancet

Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms (FUTURE) in the UK: a multicentre, superiority, parallel, open-label, randomised controlled trial - The Lancet

Click here to get full coverage on Glofitamab with Polatuzumab Vedotin in Refractory Burkitt’s Lymphoma - The New England Journal of Medicine

Glofitamab with Polatuzumab Vedotin in Refractory Burkitt’s Lymphoma  The New England Journal of Medicine

Glofitamab with Polatuzumab Vedotin in Refractory Burkitt’s Lymphoma - The New England Journal of Medicine

Click here to get full coverage on Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest - The Lancet

Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest  The Lancet

Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest - The Lancet

Click here to get full coverage on Ductilization of single-phase refractory high-entropy alloys via activation of edge dislocation - ScienceDirect.com

Ductilization of single-phase refractory high-entropy alloys via activation of edge dislocation  ScienceDirect.com

Ductilization of single-phase refractory high-entropy alloys via activation of edge dislocation - ScienceDirect.com

Click here to get full coverage on Data-driven design of novel lightweight refractory high-entropy alloys with superb hardness and corrosion resistance - Nature

Data-driven design of novel lightweight refractory high-entropy alloys with superb hardness and corrosion resistance  Nature

Data-driven design of novel lightweight refractory high-entropy alloys with superb hardness and corrosion resistance - Nature

Click here to get full coverage on Laser-based additive manufacturing of refractory metals and their alloys: A review - ScienceDirect.com

Laser-based additive manufacturing of refractory metals and their alloys: A review  ScienceDirect.com

Laser-based additive manufacturing of refractory metals and their alloys: A review - ScienceDirect.com

Click here to get full coverage on Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclax | Leukemia - Nature

Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclax | Leukemia  Nature

Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclax | Leukemia - Nature

Click here to get full coverage on Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study - ASCO Publications

Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study  ASCO Publications

Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study - ASCO Publications

Click here to get full coverage on High plasticity in refractory composite fabrication by ultrasonic additive manufacturing - ScienceDirect.com

High plasticity in refractory composite fabrication by ultrasonic additive manufacturing  ScienceDirect.com

High plasticity in refractory composite fabrication by ultrasonic additive manufacturing - ScienceDirect.com

Click here to get full coverage on Design of BCC/FCC dual-solid solution refractory high-entropy alloys through CALPHAD, machine learning and experimental methods - Nature

Design of BCC/FCC dual-solid solution refractory high-entropy alloys through CALPHAD, machine learning and experimental methods  Nature

Design of BCC/FCC dual-solid solution refractory high-entropy alloys through CALPHAD, machine learning and experimental methods - Nature

Click here to get full coverage on Designing ductile refractory high-entropy alloys - Nature

Designing ductile refractory high-entropy alloys  Nature

Designing ductile refractory high-entropy alloys - Nature

Click here to get full coverage on Mutual symbiosis of electroactive bacteria and denitrifiers for improved refractory carbon utilization and nitrate reduction - ScienceDirect.com

Mutual symbiosis of electroactive bacteria and denitrifiers for improved refractory carbon utilization and nitrate reduction  ScienceDirect.com

Mutual symbiosis of electroactive bacteria and denitrifiers for improved refractory carbon utilization and nitrate reduction - ScienceDirect.com

Click here to get full coverage on Stability of the B2 phase among refractory metals - ScienceDirect.com

Stability of the B2 phase among refractory metals  ScienceDirect.com

Stability of the B2 phase among refractory metals - ScienceDirect.com

Click here to get full coverage on Shinagawa Refractories Announces Treasury Stock Disposal for Director Compensation - TipRanks

Shinagawa Refractories Announces Treasury Stock Disposal for Director Compensation  TipRanks

Shinagawa Refractories Announces Treasury Stock Disposal for Director Compensation - TipRanks

Click here to get full coverage on Placebo responses in clinical trials of refractory chronic cough: mechanisms, challenges, and mitigation strategies - The Lancet

Placebo responses in clinical trials of refractory chronic cough: mechanisms, challenges, and mitigation strategies  The Lancet

Placebo responses in clinical trials of refractory chronic cough: mechanisms, challenges, and mitigation strategies - The Lancet

Click here to get full coverage on Mineral phase reconstruction mechanism of forsterite refractory prepared from ferronickel slag - ScienceDirect.com

Mineral phase reconstruction mechanism of forsterite refractory prepared from ferronickel slag  ScienceDirect.com

Mineral phase reconstruction mechanism of forsterite refractory prepared from ferronickel slag - ScienceDirect.com

Click here to get full coverage on Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myeloma - Nature

Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myeloma  Nature

Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myeloma - Nature

Click here to get full coverage on Redifferentiation of Radioiodine-Refractory Thyroid Cancer following Genotype-Guided MAPK/BRAF Inhibition - Journal of Nuclear Medicine

Redifferentiation of Radioiodine-Refractory Thyroid Cancer following Genotype-Guided MAPK/BRAF Inhibition  Journal of Nuclear Medicine

Redifferentiation of Radioiodine-Refractory Thyroid Cancer following Genotype-Guided MAPK/BRAF Inhibition - Journal of Nuclear Medicine

Click here to get full coverage on Degradation of the mechanical properties of NbMoTaW refractory high-entropy alloy in tension - ScienceDirect.com

Degradation of the mechanical properties of NbMoTaW refractory high-entropy alloy in tension  ScienceDirect.com

Degradation of the mechanical properties of NbMoTaW refractory high-entropy alloy in tension - ScienceDirect.com

Click here to get full coverage on Severe refractory asthma: an update - European Respiratory Society

Severe refractory asthma: an update  European Respiratory Society

Severe refractory asthma: an update - European Respiratory Society

Click here to get full coverage on Chemotherapeutic hormesis induced by the tumor microenvironment in refractory ovarian cancer - Nature

Chemotherapeutic hormesis induced by the tumor microenvironment in refractory ovarian cancer  Nature

REFRACTORY

Price Chart

Key Statistics

Technicals

About REFRACTORY

Latest News

ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes - Pharmacy Times

Early SYRUS Data Highlight Safety, Efficacy of AZD0486 in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD - AJMC

FDA Fast-Tracks MALT1 Inhibitor in Relapsed/Refractory Waldenström Macroglobulinemia - Targeted Oncology

Advanced Charts

Top Gainers

Top Losers